Order Article Reprints

Pandya PH, Jannu AJ, Bijangi-Vishehsaraei K, Dobrota E, Bailey BJ, Barghi F, Shannon HE, Riyahi N, Damayanti NP, Young C, et al. Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors. Cancers. 2023; 15(1):259. https://doi.org/10.3390/cancers15010259

Pandya, Pankita H., Asha Jacob Jannu, Khadijeh Bijangi-Vishehsaraei, Erika Dobrota, Barbara J. Bailey, Farinaz Barghi, Harlan E. Shannon, Niknam Riyahi, Nur P. Damayanti, Courtney Young, and et al. 2023. "Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors" Cancers 15, no. 1: 259. https://doi.org/10.3390/cancers15010259

Pandya, P. H., Jannu, A. J., Bijangi-Vishehsaraei, K., Dobrota, E., Bailey, B. J., Barghi, F., Shannon, H. E., Riyahi, N., Damayanti, N. P., Young, C., Malko, R., Justice, R., Albright, E., Sandusky, G. E., Wurtz, L. D., Collier, C. D., Marshall, M. S., Gallagher, R. I., Wulfkuhle, J. D., ... Pollok, K. E. (2023). Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors. Cancers, 15(1), 259. https://doi.org/10.3390/cancers15010259